Clinical Trial Update: Nirogacestat in Patients With Kaposi Sarcoma [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 trial of nirogacestat for Kaposi sarcoma that is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposi Sarcoma

Drugs mentioned

• Nirogacestat (nirogacestat)

Snippet

Sponsor: AIDS Malignancy Consortium | Conditions: AIDS-Related Kaposi Sarcoma, Skin Kaposi Sarcoma | Phase 2 | Status: NOT_YET_RECRUITING